Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells ; volume:17 ; number:1 ; day:6 ; month:9 ; year:2017 ; pages:1-13 ; date:12.2017
BMC cancer ; 17, Heft 1 (6.9.2017), 1-13, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Reikvam, Håkon
- Beteiligte Personen und Organisationen
-
Hovland, Randi
Forthun, Rakel Brendsdal
Erdal, Sigrid
Gjertsen, Bjørn Tore
Fredly, Hanne
Bruserud, Øystein
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3620-y
- URN
-
urn:nbn:de:1111-201711115084
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Reikvam, Håkon
- Hovland, Randi
- Forthun, Rakel Brendsdal
- Erdal, Sigrid
- Gjertsen, Bjørn Tore
- Fredly, Hanne
- Bruserud, Øystein
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of TP53 mutation status in elderly AML patients when adding all‐trans retinoic acid or valproic acid to decitabine
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
Thrombotic microangiopathy associated with Valproic acid toxicity
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
Valproic acid-coupled nanoparticles with anti-inflammatory activity
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Sociability: Comparing the Effect of Chlorpyrifos with Valproic Acid
Valproic Acid: One Drug, One Patient, and Multiple Reactions
Valproic acid restricts mast cell activation by Listeria monocytogenes
Impact of TP53 mutation status in elderly AML patients when adding all‐trans retinoic acid or valproic acid to decitabine
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
Thrombotic microangiopathy associated with Valproic acid toxicity
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
Valproic acid-coupled nanoparticles with anti-inflammatory activity
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Sociability: Comparing the Effect of Chlorpyrifos with Valproic Acid
Valproic Acid: One Drug, One Patient, and Multiple Reactions
Valproic acid restricts mast cell activation by Listeria monocytogenes
Impact of TP53 mutation status in elderly AML patients when adding all‐trans retinoic acid or valproic acid to decitabine
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
Thrombotic microangiopathy associated with Valproic acid toxicity
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
Valproic acid-coupled nanoparticles with anti-inflammatory activity
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Sociability: Comparing the Effect of Chlorpyrifos with Valproic Acid
Valproic Acid: One Drug, One Patient, and Multiple Reactions